BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 10, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the med-tech industry, including: Alcami, Cardio Diagnostics, Prolira.
Read More

Regulatory actions for March 9, 2023

March 9, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antev, Biogen, Biomarin, Boehringer, Eli Lilly, Inhibikase, Mesoblast, Revive, Sage.
Read More

Other news to note for March 9, 2023

March 9, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Fusion, Biocytogen, Bridgene, Carisma, Gilead, J&J, Neoleukin, Selonterra, Sesen, Surface Oncology, Takeda, Tessa.
Read More

In the clinic for March 9, 2023

March 9, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Achieve, Alterity, Biocorrx, Biothera, Cel-Sci, DBV, Fresh Tracks, JW, Molecure, Redx, Renovorx, Sernova, Sparrow, Vistagen.
Read More

Financings for March 9, 2023

March 9, 2023
Biopharmas raising money in public or private financings, including: Hemostemix, Iktos, Macrogenics, Nrx, Ring, Tiamat.
Read More

Appointments and advancements for March 9, 2023

March 9, 2023
New hires and promotions in the biopharma industry, including: Asklepios, Centogene, Evofem, Fulcrum, Homology, Lava, Nkgen, Pliant, Rome, Transgene.
Read More

Other news to note for March 8, 2023

March 8, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alimetrix, Aribio, Fujirebio, Microarrays, Miromatrix, Pharmajet, Sengine, Spectrum Solutions.
Read More

Financings for March 8, 2023

March 8, 2023
Med-tech firms raising money in public or private financings, including: Aiberry, Virax Biolabs.
Read More

Appointments and advancements for March 8, 2023

March 8, 2023
New hires and promotions in the med-tech industry, including: Accelerate Diagnostics, Aditxt, Aim Medical Robotics, Endoluxe, Heartbeam, Ivy Fertility, Maternova, Osteocentric, Swift Medical.
Read More

Regulatory actions for March 8, 2023

March 8, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biomarin, Genethon, Ionis, Novan, Regeneron, Sanofi, Shorla, Siga, Takeda.
Read More
Previous 1 2 … 851 852 853 854 855 856 857 858 859 … 1807 1808 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

    BioWorld Science
    Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
  • Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors

    BioWorld Science
    Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing